These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8000789)

  • 1. [Biochemical factors of coronary atherosclerosis risk].
    Titov VN
    Klin Lab Diagn; 1993; (4):30-7. PubMed ID: 8000789
    [No Abstract]   [Full Text] [Related]  

  • 2. A treasure trove for lipoprotein biology.
    Lusis AJ; Pajukanta P
    Nat Genet; 2008 Feb; 40(2):129-30. PubMed ID: 18227868
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis.
    Drexel H; Amann FW; Beran J; Rentsch K; Candinas R; Muntwyler J; Luethy A; Gasser T; Follath F
    Circulation; 1994 Nov; 90(5):2230-5. PubMed ID: 7955178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases.
    Nakajima K; Nakajima Y; Takeichi S; Fujita MQ
    Atherosclerosis; 2008 May; 198(1):237-46. PubMed ID: 17977545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death.
    Takeichi S; Yukawa N; Nakajima Y; Osawa M; Saito T; Seto Y; Nakano T; Saniabadi AR; Adachi M; Wang T; Nakajima K
    Atherosclerosis; 1999 Feb; 142(2):309-15. PubMed ID: 10030382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Am J Cardiol; 2006 Mar; 97(5):640-5. PubMed ID: 16490429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of non-high-density lipoprotein cholesterol determinations in the diagnosis and treatment of dyslipidemia.
    Hirsch GA; Blumenthal RS
    Am J Cardiol; 2003 Apr; 91(7):827-30. PubMed ID: 12667569
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoproteins and coronary heart disease.
    Krauss RM
    Postgrad Med; 1989 Apr; Spec No():54-8; discussion 89-90. PubMed ID: 2726627
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation of Fasting Triglyceride-Rich Lipoprotein Cholesterol to Coronary Artery Calcium Score (from the ELSA-Brasil Study).
    Bittencourt MS; Santos RD; Staniak H; Sharovsky R; Kondapally R; Vallejo-Vaz AJ; Ray KK; Bensenor I; Lotufo P
    Am J Cardiol; 2017 May; 119(9):1352-1358. PubMed ID: 28302272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dyslipoproteinemia as a coronary risk factor].
    Yamamura T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():738-45. PubMed ID: 12735059
    [No Abstract]   [Full Text] [Related]  

  • 12. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.
    Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH
    Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HDL-cholesterol-- active or passive participant in the pathogenesis of atherosclerosis].
    Artenie R; Ungureanu D; Artenie A; Botnariu G; Anisie E
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):282-7. PubMed ID: 14755929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women.
    Lamon-Fava S; Herrington DM; Reboussin DM; Sherman M; Horvath KV; Cupples LA; White C; Demissie S; Schaefer EJ; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):575-9. PubMed ID: 18174456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of small dense lowdensity lipoprotein cholesterol in type 2 diabetics with coronary artery disease.
    Huang YC; Chang PY; Hwang JS; Ning HC
    Biomed J; 2014; 37(6):375-9. PubMed ID: 25179702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
    Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
    Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglycerides and coronary risk.
    Shepherd J; Packard CJ
    Isr J Med Sci; 1996 Jun; 32(6):345-55. PubMed ID: 8682639
    [No Abstract]   [Full Text] [Related]  

  • 18. Dietary cholesterol does not increase biomarkers for chronic disease in a pediatric population from northern Mexico.
    Ballesteros MN; Cabrera RM; Saucedo Mdel S; Fernandez ML
    Am J Clin Nutr; 2004 Oct; 80(4):855-61. PubMed ID: 15447890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-HDL cholesterol as a predictor of carotid atherosclerosis in the elderly.
    Kawamoto R; Oka Y; Tomita H; Kodama A
    J Atheroscler Thromb; 2005; 12(3):143-8. PubMed ID: 16020914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.